Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)
Aim of the study. To estimate efficacy and safety of cepeginterferon-alpha 2b (cPEG-IFNα2b) and ribavirin combination for the treatment of chronic hepatitis C (CHC), to define necessity of IL-28V genetic polymorphism diagnostics, to estimate liver elastometry scores at the background of antiviral th...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Gastro LLC
2018-08-01
|
| Col·lecció: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Matèries: | |
| Accés en línia: | https://www.gastro-j.ru/jour/article/view/216 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|